PCV26 Lifetime Cost-Effectiveness Analysis of Ticagrelor in Patients With Acute Coronary Syndromes Based on the Plato Trial: A Singapore Health Care Perspective
Type
Journal articlePermalink
https://hdl.handle.net/10161/22895Published Version (Please cite this version)
10.1016/j.jval.2012.08.193Publication Info
(2012). PCV26 Lifetime Cost-Effectiveness Analysis of Ticagrelor in Patients With Acute Coronary
Syndromes Based on the Plato Trial: A Singapore Health Care Perspective. Value in Health, 15(7). pp. A632-A633. 10.1016/j.jval.2012.08.193. Retrieved from https://hdl.handle.net/10161/22895.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
David Bruce Matchar
Professor of Medicine
My research relates to clinical practice improvement - from the development of clinical
policies to their implementation in real world clinical settings. Most recently my
major content focus has been cerebrovascular disease. Other major clinical areas in
which I work include the range of disabling neurological conditions, cardiovascular
disease, and cancer prevention. Notable features of my work are: (1) reliance on
analytic strategies such as meta-analysis, simulation, decision analy
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info